MYC and lung cancer: For example, the combined actions of endogenously expressed mutant KRAS and modestly deregulated MYC expression led to NK cell‐mediated immune escape through inhibition of IFN‐I pathways in pancreatic ductal adenocarcinoma and lung cancer [46, 47].